Loading…

Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates

In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phen...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal 2018-11, Vol.24 (66), p.17523-17537
Main Authors: Martínez‐Alonso, Marta, Busto, Natalia, Aguirre, Larry Danilo, Berlanga, Leticia, Carrión, M. Carmen, Cuevas, José V., Rodríguez, Ana M., Carbayo, Arancha, Manzano, Blanca R., Ortí, Enrique, Jalón, Félix A., García, Begoña, Espino, Gustavo
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 17537
container_issue 66
container_start_page 17523
container_title Chemistry : a European journal
container_volume 24
creator Martínez‐Alonso, Marta
Busto, Natalia
Aguirre, Larry Danilo
Berlanga, Leticia
Carrión, M. Carmen
Cuevas, José V.
Rodríguez, Ana M.
Carbayo, Arancha
Manzano, Blanca R.
Ortí, Enrique
Jalón, Félix A.
García, Begoña
Espino, Gustavo
description In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phenolate‐N,O (L2, series b), and the C^N ligands are 2‐(phenyl)pyridinate or its derivatives, are described,. Complexes of types a and b exhibit dissimilar photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that derivatives of series a are harmless in the dark against SW480 cancer cells (colon adenocarcinoma), but express enhanced cytotoxicity versus the same cells after stimulation with UV or blue light. In contrast, complexes of type b show a very high cytotoxic activity in the dark, but low photosensitizing ability. Thus, the ancillary N^O ligand is the main factor in terms of cytotoxic activity both in the dark and upon irradiation. However, the C^N ligands play a key role regarding cellular uptake. In particular, the complex of formula [Ir(dfppy)2(L1)] (dfppy=2‐(4,6‐difluorophenyl)pyridinate) [3 a] has been identified as both an efficient photosensitizer for 1O2 generation and a potential agent for photodynamic therapy. These capabilities are probably related to a combination of its notable cellular internalization, remarkable photostability, high photoluminescence quantum yield, and long triplet excited‐state lifetime. Both types of complexes exhibit notable catalytic activity in the photooxidation of thioanisole and S‐containing aminoacids with full selectivity. Phototherapy: Influence of the ancillary ligand on the PDT properties of IrIII complexes—two series of IrIII complexes with 2‐benzoazole‐phenolates are described, and their anticancer activity both in the dark and under irradiation are evaluated.
doi_str_mv 10.1002/chem.201803784
format article
fullrecord <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_miscellaneous_2099041948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138675046</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2734-e192d74e043237c113724c6355887b7e9eff592fcbeed6159e61a871c769b7143</originalsourceid><addsrcrecordid>eNpdkc1uEzEUhS0EEqGwZW2JDZtp_Tfj8bKJCh0pQCRgbTmeO4krjx08nkK64hF4ib4YT4JDUResro7ud4-O7kHoNSXnlBB2YfcwnjNCW8JlK56gBa0Zrbhs6qdoQZSQVVNz9Ry9mKYbQohqOF-g-885xbDDXRj8DMECjgPOe8CXwTrvTTritduZ0ON4C-nvZrOPOfbHYEZnC5adNeUu4U2KB0jZwXTy-AhzTsbjpZvs0fo4QjbeZOhxl7quw6s4Hjz8KPASTHIlAvv989cSwl00d9FDEZs9hHi6mV6iZ4PxE7z6N8_Q13dXX1bX1frT-251ua52THJRAVWslwKI4IxLSymXTNiG13Xbyq0EBcNQKzbYLUDf0FpBQ00rqZWN2koq-Bl6--B7SPHbDFPWY4kP5Q8B4jxpRpQigirRFvTNf-hNnFMo6TSjvG1kTURTKPVAfXcejvqQ3FheqinRp8r0qTL9WJleXV99eFT8Dy0JkMI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2138675046</pqid></control><display><type>article</type><title>Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates</title><source>Wiley</source><creator>Martínez‐Alonso, Marta ; Busto, Natalia ; Aguirre, Larry Danilo ; Berlanga, Leticia ; Carrión, M. Carmen ; Cuevas, José V. ; Rodríguez, Ana M. ; Carbayo, Arancha ; Manzano, Blanca R. ; Ortí, Enrique ; Jalón, Félix A. ; García, Begoña ; Espino, Gustavo</creator><creatorcontrib>Martínez‐Alonso, Marta ; Busto, Natalia ; Aguirre, Larry Danilo ; Berlanga, Leticia ; Carrión, M. Carmen ; Cuevas, José V. ; Rodríguez, Ana M. ; Carbayo, Arancha ; Manzano, Blanca R. ; Ortí, Enrique ; Jalón, Félix A. ; García, Begoña ; Espino, Gustavo</creatorcontrib><description>In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phenolate‐N,O (L2, series b), and the C^N ligands are 2‐(phenyl)pyridinate or its derivatives, are described,. Complexes of types a and b exhibit dissimilar photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that derivatives of series a are harmless in the dark against SW480 cancer cells (colon adenocarcinoma), but express enhanced cytotoxicity versus the same cells after stimulation with UV or blue light. In contrast, complexes of type b show a very high cytotoxic activity in the dark, but low photosensitizing ability. Thus, the ancillary N^O ligand is the main factor in terms of cytotoxic activity both in the dark and upon irradiation. However, the C^N ligands play a key role regarding cellular uptake. In particular, the complex of formula [Ir(dfppy)2(L1)] (dfppy=2‐(4,6‐difluorophenyl)pyridinate) [3 a] has been identified as both an efficient photosensitizer for 1O2 generation and a potential agent for photodynamic therapy. These capabilities are probably related to a combination of its notable cellular internalization, remarkable photostability, high photoluminescence quantum yield, and long triplet excited‐state lifetime. Both types of complexes exhibit notable catalytic activity in the photooxidation of thioanisole and S‐containing aminoacids with full selectivity. Phototherapy: Influence of the ancillary ligand on the PDT properties of IrIII complexes—two series of IrIII complexes with 2‐benzoazole‐phenolates are described, and their anticancer activity both in the dark and under irradiation are evaluated.</description><identifier>ISSN: 0947-6539</identifier><identifier>EISSN: 1521-3765</identifier><identifier>DOI: 10.1002/chem.201803784</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>2-arylazoles ; Adenocarcinoma ; anticancer complexes ; Anticancer properties ; Biological properties ; Catalysis ; Catalytic activity ; Chemistry ; Colon ; Colon cancer ; Cytotoxicity ; Derivatives ; heteroleptic neutral iridium(III) complexes ; Internalization ; Iridium ; Irradiation ; Ligands ; phosphorescent complexes ; Photodynamic therapy ; Photoluminescence ; Photons ; Photooxidation ; Photosensitization ; Selectivity ; Thioanisole ; Toxicity ; Ultraviolet radiation</subject><ispartof>Chemistry : a European journal, 2018-11, Vol.24 (66), p.17523-17537</ispartof><rights>2018 Wiley‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-4738-4323 ; 0000-0002-4908-4503 ; 0000-0002-0931-5274 ; 0000-0001-9637-1209 ; 0000-0002-6622-044X ; 0000-0003-4602-7500 ; 0000-0002-0817-1651 ; 0000-0002-2421-1529 ; 0000-0001-9544-8286 ; 0000-0001-5617-5705</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Martínez‐Alonso, Marta</creatorcontrib><creatorcontrib>Busto, Natalia</creatorcontrib><creatorcontrib>Aguirre, Larry Danilo</creatorcontrib><creatorcontrib>Berlanga, Leticia</creatorcontrib><creatorcontrib>Carrión, M. Carmen</creatorcontrib><creatorcontrib>Cuevas, José V.</creatorcontrib><creatorcontrib>Rodríguez, Ana M.</creatorcontrib><creatorcontrib>Carbayo, Arancha</creatorcontrib><creatorcontrib>Manzano, Blanca R.</creatorcontrib><creatorcontrib>Ortí, Enrique</creatorcontrib><creatorcontrib>Jalón, Félix A.</creatorcontrib><creatorcontrib>García, Begoña</creatorcontrib><creatorcontrib>Espino, Gustavo</creatorcontrib><title>Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates</title><title>Chemistry : a European journal</title><description>In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phenolate‐N,O (L2, series b), and the C^N ligands are 2‐(phenyl)pyridinate or its derivatives, are described,. Complexes of types a and b exhibit dissimilar photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that derivatives of series a are harmless in the dark against SW480 cancer cells (colon adenocarcinoma), but express enhanced cytotoxicity versus the same cells after stimulation with UV or blue light. In contrast, complexes of type b show a very high cytotoxic activity in the dark, but low photosensitizing ability. Thus, the ancillary N^O ligand is the main factor in terms of cytotoxic activity both in the dark and upon irradiation. However, the C^N ligands play a key role regarding cellular uptake. In particular, the complex of formula [Ir(dfppy)2(L1)] (dfppy=2‐(4,6‐difluorophenyl)pyridinate) [3 a] has been identified as both an efficient photosensitizer for 1O2 generation and a potential agent for photodynamic therapy. These capabilities are probably related to a combination of its notable cellular internalization, remarkable photostability, high photoluminescence quantum yield, and long triplet excited‐state lifetime. Both types of complexes exhibit notable catalytic activity in the photooxidation of thioanisole and S‐containing aminoacids with full selectivity. Phototherapy: Influence of the ancillary ligand on the PDT properties of IrIII complexes—two series of IrIII complexes with 2‐benzoazole‐phenolates are described, and their anticancer activity both in the dark and under irradiation are evaluated.</description><subject>2-arylazoles</subject><subject>Adenocarcinoma</subject><subject>anticancer complexes</subject><subject>Anticancer properties</subject><subject>Biological properties</subject><subject>Catalysis</subject><subject>Catalytic activity</subject><subject>Chemistry</subject><subject>Colon</subject><subject>Colon cancer</subject><subject>Cytotoxicity</subject><subject>Derivatives</subject><subject>heteroleptic neutral iridium(III) complexes</subject><subject>Internalization</subject><subject>Iridium</subject><subject>Irradiation</subject><subject>Ligands</subject><subject>phosphorescent complexes</subject><subject>Photodynamic therapy</subject><subject>Photoluminescence</subject><subject>Photons</subject><subject>Photooxidation</subject><subject>Photosensitization</subject><subject>Selectivity</subject><subject>Thioanisole</subject><subject>Toxicity</subject><subject>Ultraviolet radiation</subject><issn>0947-6539</issn><issn>1521-3765</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkc1uEzEUhS0EEqGwZW2JDZtp_Tfj8bKJCh0pQCRgbTmeO4krjx08nkK64hF4ib4YT4JDUResro7ud4-O7kHoNSXnlBB2YfcwnjNCW8JlK56gBa0Zrbhs6qdoQZSQVVNz9Ry9mKYbQohqOF-g-885xbDDXRj8DMECjgPOe8CXwTrvTTritduZ0ON4C-nvZrOPOfbHYEZnC5adNeUu4U2KB0jZwXTy-AhzTsbjpZvs0fo4QjbeZOhxl7quw6s4Hjz8KPASTHIlAvv989cSwl00d9FDEZs9hHi6mV6iZ4PxE7z6N8_Q13dXX1bX1frT-251ua52THJRAVWslwKI4IxLSymXTNiG13Xbyq0EBcNQKzbYLUDf0FpBQ00rqZWN2koq-Bl6--B7SPHbDFPWY4kP5Q8B4jxpRpQigirRFvTNf-hNnFMo6TSjvG1kTURTKPVAfXcejvqQ3FheqinRp8r0qTL9WJleXV99eFT8Dy0JkMI</recordid><startdate>20181127</startdate><enddate>20181127</enddate><creator>Martínez‐Alonso, Marta</creator><creator>Busto, Natalia</creator><creator>Aguirre, Larry Danilo</creator><creator>Berlanga, Leticia</creator><creator>Carrión, M. Carmen</creator><creator>Cuevas, José V.</creator><creator>Rodríguez, Ana M.</creator><creator>Carbayo, Arancha</creator><creator>Manzano, Blanca R.</creator><creator>Ortí, Enrique</creator><creator>Jalón, Félix A.</creator><creator>García, Begoña</creator><creator>Espino, Gustavo</creator><general>Wiley Subscription Services, Inc</general><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4738-4323</orcidid><orcidid>https://orcid.org/0000-0002-4908-4503</orcidid><orcidid>https://orcid.org/0000-0002-0931-5274</orcidid><orcidid>https://orcid.org/0000-0001-9637-1209</orcidid><orcidid>https://orcid.org/0000-0002-6622-044X</orcidid><orcidid>https://orcid.org/0000-0003-4602-7500</orcidid><orcidid>https://orcid.org/0000-0002-0817-1651</orcidid><orcidid>https://orcid.org/0000-0002-2421-1529</orcidid><orcidid>https://orcid.org/0000-0001-9544-8286</orcidid><orcidid>https://orcid.org/0000-0001-5617-5705</orcidid></search><sort><creationdate>20181127</creationdate><title>Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates</title><author>Martínez‐Alonso, Marta ; Busto, Natalia ; Aguirre, Larry Danilo ; Berlanga, Leticia ; Carrión, M. Carmen ; Cuevas, José V. ; Rodríguez, Ana M. ; Carbayo, Arancha ; Manzano, Blanca R. ; Ortí, Enrique ; Jalón, Félix A. ; García, Begoña ; Espino, Gustavo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2734-e192d74e043237c113724c6355887b7e9eff592fcbeed6159e61a871c769b7143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>2-arylazoles</topic><topic>Adenocarcinoma</topic><topic>anticancer complexes</topic><topic>Anticancer properties</topic><topic>Biological properties</topic><topic>Catalysis</topic><topic>Catalytic activity</topic><topic>Chemistry</topic><topic>Colon</topic><topic>Colon cancer</topic><topic>Cytotoxicity</topic><topic>Derivatives</topic><topic>heteroleptic neutral iridium(III) complexes</topic><topic>Internalization</topic><topic>Iridium</topic><topic>Irradiation</topic><topic>Ligands</topic><topic>phosphorescent complexes</topic><topic>Photodynamic therapy</topic><topic>Photoluminescence</topic><topic>Photons</topic><topic>Photooxidation</topic><topic>Photosensitization</topic><topic>Selectivity</topic><topic>Thioanisole</topic><topic>Toxicity</topic><topic>Ultraviolet radiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez‐Alonso, Marta</creatorcontrib><creatorcontrib>Busto, Natalia</creatorcontrib><creatorcontrib>Aguirre, Larry Danilo</creatorcontrib><creatorcontrib>Berlanga, Leticia</creatorcontrib><creatorcontrib>Carrión, M. Carmen</creatorcontrib><creatorcontrib>Cuevas, José V.</creatorcontrib><creatorcontrib>Rodríguez, Ana M.</creatorcontrib><creatorcontrib>Carbayo, Arancha</creatorcontrib><creatorcontrib>Manzano, Blanca R.</creatorcontrib><creatorcontrib>Ortí, Enrique</creatorcontrib><creatorcontrib>Jalón, Félix A.</creatorcontrib><creatorcontrib>García, Begoña</creatorcontrib><creatorcontrib>Espino, Gustavo</creatorcontrib><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Chemistry : a European journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez‐Alonso, Marta</au><au>Busto, Natalia</au><au>Aguirre, Larry Danilo</au><au>Berlanga, Leticia</au><au>Carrión, M. Carmen</au><au>Cuevas, José V.</au><au>Rodríguez, Ana M.</au><au>Carbayo, Arancha</au><au>Manzano, Blanca R.</au><au>Ortí, Enrique</au><au>Jalón, Félix A.</au><au>García, Begoña</au><au>Espino, Gustavo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates</atitle><jtitle>Chemistry : a European journal</jtitle><date>2018-11-27</date><risdate>2018</risdate><volume>24</volume><issue>66</issue><spage>17523</spage><epage>17537</epage><pages>17523-17537</pages><issn>0947-6539</issn><eissn>1521-3765</eissn><abstract>In this paper, the synthesis, comprehensive characterization and biological and photocatalytic properties of two series of neutral IrIII biscyclometalated complexes of general formula [Ir(C^N)2(N^O)], where the N^O ligands are 2‐(benzimidazolyl)phenolate‐N,O (L1, series a) and 2‐(benzothiazolyl)phenolate‐N,O (L2, series b), and the C^N ligands are 2‐(phenyl)pyridinate or its derivatives, are described,. Complexes of types a and b exhibit dissimilar photophysical and biological properties. In vitro cytotoxicity tests conclusively prove that derivatives of series a are harmless in the dark against SW480 cancer cells (colon adenocarcinoma), but express enhanced cytotoxicity versus the same cells after stimulation with UV or blue light. In contrast, complexes of type b show a very high cytotoxic activity in the dark, but low photosensitizing ability. Thus, the ancillary N^O ligand is the main factor in terms of cytotoxic activity both in the dark and upon irradiation. However, the C^N ligands play a key role regarding cellular uptake. In particular, the complex of formula [Ir(dfppy)2(L1)] (dfppy=2‐(4,6‐difluorophenyl)pyridinate) [3 a] has been identified as both an efficient photosensitizer for 1O2 generation and a potential agent for photodynamic therapy. These capabilities are probably related to a combination of its notable cellular internalization, remarkable photostability, high photoluminescence quantum yield, and long triplet excited‐state lifetime. Both types of complexes exhibit notable catalytic activity in the photooxidation of thioanisole and S‐containing aminoacids with full selectivity. Phototherapy: Influence of the ancillary ligand on the PDT properties of IrIII complexes—two series of IrIII complexes with 2‐benzoazole‐phenolates are described, and their anticancer activity both in the dark and under irradiation are evaluated.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/chem.201803784</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-4738-4323</orcidid><orcidid>https://orcid.org/0000-0002-4908-4503</orcidid><orcidid>https://orcid.org/0000-0002-0931-5274</orcidid><orcidid>https://orcid.org/0000-0001-9637-1209</orcidid><orcidid>https://orcid.org/0000-0002-6622-044X</orcidid><orcidid>https://orcid.org/0000-0003-4602-7500</orcidid><orcidid>https://orcid.org/0000-0002-0817-1651</orcidid><orcidid>https://orcid.org/0000-0002-2421-1529</orcidid><orcidid>https://orcid.org/0000-0001-9544-8286</orcidid><orcidid>https://orcid.org/0000-0001-5617-5705</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0947-6539
ispartof Chemistry : a European journal, 2018-11, Vol.24 (66), p.17523-17537
issn 0947-6539
1521-3765
language eng
recordid cdi_proquest_miscellaneous_2099041948
source Wiley
subjects 2-arylazoles
Adenocarcinoma
anticancer complexes
Anticancer properties
Biological properties
Catalysis
Catalytic activity
Chemistry
Colon
Colon cancer
Cytotoxicity
Derivatives
heteroleptic neutral iridium(III) complexes
Internalization
Iridium
Irradiation
Ligands
phosphorescent complexes
Photodynamic therapy
Photoluminescence
Photons
Photooxidation
Photosensitization
Selectivity
Thioanisole
Toxicity
Ultraviolet radiation
title Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated IrIII Complexes Bearing 2‐Benzoazole‐Phenolates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A17%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strong%20Influence%20of%20the%20Ancillary%20Ligand%20over%20the%20Photodynamic%20Anticancer%20Properties%20of%20Neutral%20Biscyclometalated%20IrIII%20Complexes%20Bearing%202%E2%80%90Benzoazole%E2%80%90Phenolates&rft.jtitle=Chemistry%20:%20a%20European%20journal&rft.au=Mart%C3%ADnez%E2%80%90Alonso,%20Marta&rft.date=2018-11-27&rft.volume=24&rft.issue=66&rft.spage=17523&rft.epage=17537&rft.pages=17523-17537&rft.issn=0947-6539&rft.eissn=1521-3765&rft_id=info:doi/10.1002/chem.201803784&rft_dat=%3Cproquest_wiley%3E2138675046%3C/proquest_wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g2734-e192d74e043237c113724c6355887b7e9eff592fcbeed6159e61a871c769b7143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2138675046&rft_id=info:pmid/&rfr_iscdi=true